Andean Precious Metals (CVE:APM) Shares Down 5.1% – Should You Sell?

Andean Precious Metals Corp. (CVE:APM) shares were down 5.1% during trading on Friday . The company traded as low as C$1.26 and last traded at C$1.29. Approximately 88,871 shares were traded during trading, a decline of 54% from the average daily volume of 192,505 shares. The stock had previously closed at C$1.36.

Analyst Upgrades and Downgrades

Separately, Desjardins raised Andean Precious Metals to a “moderate buy” rating in a report on Thursday, October 31st.

Andean Precious Metals Stock Down 5.1 %

The firm has a 50-day moving average price of C$1.46 and a two-hundred day moving average price of C$1.25. The firm has a market cap of C$192.67 million, a PE ratio of 3.39 and a beta of 1.22.

Insider Transactions at Andean Precious Metals

In related news, insider 2176423 Ontario Ltd. bought 84,400 shares of the business’s stock in a transaction on Tuesday, October 8th. The stock was acquired at an average cost of C$1.51 per share, with a total value of C$127,359.60. Over the last three months, insiders have acquired 306,200 shares of company stock valued at $432,953. Corporate insiders own 69.37% of the company’s stock.

Andean Precious Metals Company Profile

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.